CCL2 and acrodermatitis enteropathica: This study aimed to determine whether RS504393, a selective CCR2 antagonist, can inhibit the progression of AE by blocking the CCL2-CCR2 axis and modulating its downstream pathogenic mechanisms.<h4>Methods</h4>In this study, bioinformatics analysis of the GSE124362 dataset was combined with molecular docking simulations.